H. Saito

发表

Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.

Yoshio Miki, Keiko Taguchi, Shinobu Imajoh-Ohmi, 2007, Biochemical and biophysical research communications.

Human Regulatory Factor X 4 (RFX4) Is a Testis-specific Dimeric DNA-binding Protein That Cooperates with Other Human RFX Members*

Yoshio Miki, Y. Miki, Zijie Sun, 2002, The Journal of Biological Chemistry.

Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer

T. Katagiri, Y. Nakamura, Y. Miki, 1999, Genes, chromosomes & cancer.

CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.

Y. Miki, Doudou Zhang, H. Saito, 2021, Biochemical and biophysical research communications.

Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation.

Y. Nakamura, M. Emi, H. Saito, 1995, Human molecular genetics.

Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers.

Y. Nakamura, R. Kudo, S. Saito, 1992, Cancer research.

Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death.

Y. Furukawa, Y. Nakamura, S. Takami, 1995, Cytogenetics and cell genetics.

A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2

Y. Miki, A. Nakanishi, H. Saito, 2008, Oncogene.

Lano, a Novel LAP Protein Directly Connected to MAGUK Proteins in Epithelial Cells*

D. Birnbaum, A. Le Bivic, J. Borg, 2001, The Journal of Biological Chemistry.

[PARP inhibitors for cancer therapy].

Y. Miki, H. Saito, 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.

H. Konishi, H. Osada, T. Harano, 2002, Cancer research.

Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines

Y. Miki, F. Akiyama, Masahiro Kato, 2002, Breast cancer.

Nuclear localization signals of the BRCA2 protein.

Y. Miki, H. Saito, M. Kato, 2000, Biochemical and biophysical research communications.

Multiple possible sites of BRAC2 interacting with DNA repair protein RAD51

T. Katagiri, Y. Nakamura, Y. Miki, 1998, Genes, chromosomes & cancer.

The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer.

M. Skolnick, Y. Miki, T. Sato, 1992, Cancer research.

A novel metalloprotease/disintegrin–like gene at 17q21.3 is somatically rearranged in two primary breast cancers

T. Katagiri, J. Inazawa, M. Emi, 1993, Nature genetics.

The human prohibitin (PHB) gene family and its somatic mutations in human tumors.

Y. Nakamura, T. Sato, H. Saito, 1993, Genomics.

High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization.

Y. Nakamura, J. Inazawa, T. Abe, 1993, Genomics.

BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein

Y. Miki, A. Nakanishi, H. Saito, 2016, Cell cycle.

Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis

H. Osada, Takashi Takahashi, T. Hida, 2001, Oncogene.

Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.

Y. Nakamura, J. Inazawa, R. Kudo, 1993, Cancer research.

Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers.

Takashi Takahashi, T. Nakagawa, H. Saito, 2003, The American journal of pathology.

Allelotype of Human Ovarian Cancer 1

Yusuke Nakamura, R. Morita, H. Saito, 2006 .

Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1.

K. Yoshimoto, T. Sekiya, H. Iwahana, 1989, Cancer research.

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer

Y. Yatabe, H. Konishi, H. Osada, 2003, Oncogene.

Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer.

H. Konishi, H. Osada, T. Harano, 2000, Cancer research.

Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population

Y. Kamatani, Yusuke Nakamura, T. Katagiri, 2019, Scientific Reports.

Identification of Rad51 alteration in patients with bilateral breast cancer

Yusuke Nakamura, T. Katagiri, Y. Miki, 2000, Journal of Human Genetics.

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients

Y. Yatabe, T. Mitsudomi, H. Osada, 2004, International journal of cancer.

Allelotype of human ovarian cancer.

Y. Nakamura, T. Sato, J. H. Lee, 1991, Cancer research.

Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumors of early onset and/or of poorly differentiated type

Y. Nakamura, R. Kudo, H. Saito, 1995, Genes, chromosomes & cancer.

ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor

D. Birnbaum, B. Margolis, J. Borg, 2000, Nature Cell Biology.

Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high‐resolution physical map with 29 markers

D. Ledbetter, A. Tanigami, Yusuke Nakamura, 1994, Genes, chromosomes & cancer.

Advances in Brief Histological Type-selective , Tumor-predominant Expression of a Novel CHK 1 Isoform and Infrequent in Vivo Somatic CHK 2 Mutation in Small Cell Lung Cancer 1

H. Konishi, H. Osada, T. Harano, 2000 .

BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC.

Y. Miki, A. Nakanishi, H. Saito, 2014, Cancer research.

Cloning and mapping of a human novel cDNA (NHP2L1) that encodes a protein highly homologous to yeast nuclear protein NHP2.

Y. Nakamura, T. Fujiwara, H. Saito, 1996, Cytogenetics and cell genetics.

Interaction between Erbin and a Catenin-related Protein in Epithelial Cells*

Daniel Birnbaum, Jean-Paul Borg, D. Birnbaum, 2002, The Journal of Biological Chemistry.

The ERBB2/HER2 Receptor Differentially Interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 Domain Proteins*

D. Birnbaum, A. Le Bivic, J. Borg, 2001, The Journal of Biological Chemistry.

Identification and characterization of the human protein kinase-like gene NTKL: mitosis-specific centrosomal localization of an alternatively spliced isoform.

Y. Miki, Masahiro Kato, Ken-ichi Yano, 2002, Genomics.

Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.

S. Nomoto, H. Osada, T. Harano, 2001, Cancer letters.

BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization

Y. Miki, M. Kaminishi, Y. Seto, 2009, Cancer science.

Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP).

Y. Miki, K. Miyaguchi, A. Nakanishi, 2014, Biochemical and biophysical research communications.

Mutational Analysis of Mismatch Repair Genes, hMLH1 and hMSH2, in Sporadic Endometrial Carcinomas with Microsatellite Instability

Yusuke Nakamura, R. Kudo, H. Saito, 1996, Japanese journal of cancer research : Gann.

Frequent association of alternative splicing of NER, a nuclear hormone receptor gene in cancer tissues

Yusuke Nakamura, J. Inazawa, T. Nishihira, 1997, Oncogene.

Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.

Y. Nakamura, J. Inazawa, R. Kudo, 1993, Cancer Research.

BRCA2 regulates cytokinesis by myosin-IIC ATPase activation 1 BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by non-muscle myosin IIC

Y. Miki, A. Nakanishi, H. Saito, 2013 .

Six microsatellite polymorphisms at candidate and confirmed tumour suppressor gene loci.

A. Tanigami, Y. Nakamura, M. Jones, 1994, Human molecular genetics.

Isolation and mapping of a novel human gene encoding a protein containing zinc-finger structures.

Y. Nakamura, T. Fujiwara, H. Saito, 1996, Genomics.